Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Denial Of Saw Palmetto Health Claim For BPH Prompts Lawsuit

This article was originally published in The Tan Sheet

Executive Summary

FDA's denial of a health claim relating to saw palmetto and benign prostatic hyperplasia violates the First Amendment, the Nutrition Labeling & Education Act (NLEA) and the Administrative Procedures Act (APA), Washington, D.C.-based Emord & Associates asserts in a suit filed Dec. 7.

You may also be interested in...



Supreme Court Urged To Deny Saw Palmetto Health Claim Review

The Supreme Court should refuse to consider the appropriateness of a proposed saw palmetto/prostatic hyperplasia health claim due to the petitioners' misinterpretation of the FD&C Act, Acting Solicitor General Paul Clemente maintains

Supreme Court Urged To Deny Saw Palmetto Health Claim Review

The Supreme Court should refuse to consider the appropriateness of a proposed saw palmetto/prostatic hyperplasia health claim due to the petitioners' misinterpretation of the FD&C Act, Acting Solicitor General Paul Clemente maintains

Supreme Court Urged To Deny Saw Palmetto Health Claim Review

The Supreme Court should refuse to consider the appropriateness of a proposed saw palmetto/prostatic hyperplasia health claim due to the petitioners' misinterpretation of the FD&C Act, Acting Solicitor General Paul Clemente maintains

Related Content

Topics

UsernamePublicRestriction

Register

PS090668

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel